Comparative evaluation of colistin susceptibility testing methods among carbapenem-nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii clinical isolates

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 8, 2015, Pages 4625-4630

  Dafopoulou, Konstantina ^a,b   Zarkotou, Olympia ^a   Dimitroulia, Evangelia ^a   Hadjichristodoulou, Christos ^b   Gennimata, Vasiliki ^a   Pournaras, Spyros ^a   Tsakris, Athanasios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIN; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM ISOLATE; BROTH DILUTION; CASE REPORT; COMPARATIVE STUDY; DRUG ACTIVITY; DRUG SCREENING; EPSILOMETER TEST; ESCHERICHIA COLI; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; ACINETOBACTER INFECTIONS; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; PROCEDURES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

EID: 84939808787     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00868-15     Document Type: Article

References (30)

1. Landman D, Georgescu C, Martin DA, Quale J. 2008. Polymyxins revisited. Clin Microbiol Rev 21:449-465. http://dx.doi.org/10.1128/CMR.00006-08.
2. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. 2006. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 6:589-601. http://dx.doi.org/10.1016/S1473-3099(06)70580-1.
3. Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD. 2015. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis 15:225-234. http://dx.doi.org/10.1016/S1473-3099(14)70850-3.
4. Karaiskos I, Giamarellou H. 2014. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother 15:1351-1370. http://dx.doi.org/10.1517/14656566.2014.914172.
5. Sader HS, Farrell DJ, Flamm RK, Jones RN. 2014. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). Diagn Microbiol Infect Dis 78:443-448. http://dx.doi.org/10.1016/j.diagmicrobio.2013.11.025.
6. Ah YM, Kim AJ, Lee JY. 2014. Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents 44:8-15. http://dx.doi.org/10.1016/j.ijantimicag.2014.02.016.
7. Cai Y, Chai D, Wang R, Liang B, Bai N. 2012. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 67:1607-1615. http://dx.doi.org/10.1093/jac/dks084.
8. European Centre for Disease Prevention and Control. 2013. Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). European Centre for Disease Prevention and Control, Stockholm, Sweden. http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2013.pdf.
9. Zarkotou O, Pournaras S, Voulgari E, Chrysos G, Prekates A, Voutsinas D, Themeli-Digalaki K, Tsakris A. 2010. Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study. J Clin Microbiol 48:2271-2274. http://dx.doi.org/10.1128/JCM.02301-09.
10. Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, Santangelo C, Castiglione G, Giaquinta L, Romeo MA, Vrioni G, Tsakris A. 2014. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect 86:260-266. http://dx.doi.org/10.1016/j.jhin.2014.02.001.
11. Humphries RM. 2015. Susceptibility testing of the polymyxins: where are we now? Pharmacotherapy 35:22-27. http://dx.doi.org/10.1002/phar.1505.
12. Gales AC, Reis AO, Jones RN. 2001. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 39:183-190. http://dx.doi.org/10.1128/JCM.39.1.183-190.2001.
13. Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, van Keulen PH. 2007. Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 51:3726-3730. http://dx.doi.org/10.1128/AAC.01406-06.
14. Maalej SM, Meziou MR, Rhimi FM, Hammami A. 2011. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae. Lett Appl Microbiol 53:546-551. http://dx.doi.org/10.1111/j.1472-765X.2011.03145.x.
15. Arroyo LA, García-Curiel A, Pachón-Ibañez ME, Llanos AC, Ruiz M, Pachón J, Aznar J. 2005. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43:903-905. http://dx.doi.org/10.1128/JCM.43.2.903-905.2005.
16. Lee SY, Shin JH, Lee K, Joo MY, Park KH, Shin MG, Suh SP, Ryang DW, Kim SH. 2013. Comparison of the Vitek2, MicroScan, and Etest methods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of Acinetobacter species from a Korean university hospital. J Clin Microbiol 51:1924-1926. http://dx.doi.org/10.1128/JCM.00427-13.
17. Goldstein FW, Ly A, Kitzis MD. 2007. Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin. J Antimicrob Chemother 59:1039-1040. http://dx.doi.org/10.1093/jac/dkm046.
18. Hindler JA, Humphries RM. 2013. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J Clin Microbiol 51:1678-1684. http://dx.doi.org/10.1128/JCM.03385-12.
19. Tan TY, Ng SY. 2007. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. Clin Microbiol Infect 13:541-544. http://dx.doi.org/10.1111/j.1469-0691.2007.01708.x.
20. th ed. CLSI document M07-A10. Clinical and Laboratory Standards Institute, Wayne, PA.
21. Albur M, Noel A, Bowker K, Macgowan A. 2014. Colistin susceptibility testing: time for a review. J Antimicrob Chemother 69:1432-1434. http://dx.doi.org/10.1093/jac/dkt503.
22. st Intersci Conf Antimicrob Agents Chemother, Chicago, IL, 17 to 20 September 2011.
23. Sader HS, Rhomberg PR, Flamm RK, Jones RN. 2012. Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin. Diagn Microbiol Infect Dis 74:412-414. http://dx.doi.org/10.1016/j.diagmicrobio.2012.08.025.
24. th informational supplement. CLSI document M100-S25. Clinical and Laboratory Standards Institute, Wayne, PA.
25. EUCAST. 1 January 2015. Breakpoint tables for interpretation of MICs and zone diameters, version 5.0. EUCAST Laboratory for Antimicrobial Susceptibility Testing, Växjö, Sweden. http://www.eucast.org/clinical-breakpoints/.
26. rd ed. CLSI document M23-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
27. International Organization for Standardization. 2007. ISO 20776-2: 2007(E). Clinical laboratory testing and in vitro diagnostic test systems. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Part 2: evaluation of performance of antimicrobial susceptibility test devices. International Organization for Standardization, Geneva, Switzerland.
28. Sutherland CA, Nicolau DP. 2014. To add or not to add polysorbate 80: impact on colistin MICs for clinical strains of Enterobacteriaceae and Pseudomonas aeruginosa and quality controls. J Clin Microbiol 52:3810. http://dx.doi.org/10.1128/JCM.01454-14.
29. Jayol A, Nordmann P, Brink A, Poirel L. 2015. Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system. Antimicrob Agents Chemother 59:2780-2784. http://dx.doi.org/10.1128/AAC.05055-14.
30. th Intersci Conf Antimicrob Agents Chemother. American Society for Microbiology, Washington, DC.